Pharmaceutical Executive-01-10-2007

Biotech companies, for years at the mercy of their deep-pocketed pharma partners, are finally holding the strings.

Cardio competitors team up to find new ways of preventing heart attacks.

(And the Times' front-page pounding had nothing to do with it.)